Liver transplantation outcomes for early-stage hepatocellular carcinoma: Results of a multicenter study

被引:114
|
作者
Leung, JY
Zhu, AX
Gordon, FD
Pratt, DS
Mithoefer, A
Garrigan, K
Terella, A
Hertl, M
Cosimi, AB
Chung, RT
机构
[1] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Transplant Unit, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[5] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA
[6] Tufts Univ, New England Med Ctr, Boston, MA 02111 USA
[7] Lahey Clin Fdn, Burlington, MA 01805 USA
关键词
D O I
10.1002/lt.20311
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The incidence of hepatocellular carcinoma (HCC), a frequent and incurable complication of cirrhosis, continues to rise. Orthotopic liver transplantation (OLT) has been proposed as a treatment for unresectable, intrahepatic HCC limited in extent to the Milan criteria adopted by the United Network of Organ Sharing (UNOS) in 1998. More recently, somewhat less restrictive University of California, San Francisco (UCSF)(10), criteria were proposed. To examine the long-term outcomes of OLT for HCC patients and to assess the UNOS policy of assigning weighted allocation points to patients with HCC, we retrospectively analyzed 144 patients (113 after 1998) with HCC who underwent OLT over an 11-year period at 3 institutions from UNOS Region 1. We compared their outcomes with 525 patients (272 after 1998) who underwent OLT for nonmalignant liver disease. The 1- and 5-year survival rates were 80.3% and 46.7%, respectively, for patients with HCC and 81.5% and 70.6%, respectively, for patients without HCC (P =.020). However, there was no difference in survival between HCC and non-HCC patients after implementation of disease-specific allocation for HCC in 1998. A higher proportion of the HCC cohort was older and male and had chronic HCV infection and alcoholic liver disease. In univariate analysis, having alpha-fetoprotein (AFP) levels of 10 ng/mL or less and meeting clinical and pathologic UCSF criteria were each significant predictors of improved survival (P =.005, P =.02, and P =.03, respectively). AFP greater than 10 ng/mL and exceeding pathologic UCSF criteria were also significant predictors of recurrence (P =.003 and P =.02, respectively). In conclusion, taken together, our data suggest that OLT is an acceptable option for patients with early HCC and that UCSF criteria predict outcome better than Milan or UNOS criteria. Regardless of which criteria are adopted to define eligibility, strict adherence to the criteria is important to achieve acceptable outcomes.
引用
收藏
页码:1343 / 1354
页数:12
相关论文
共 50 条
  • [1] Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis:: Results of a multicenter study
    Figueras, J
    Ibañez, L
    Ramos, E
    Jaurrieta, E
    Ortiz-de-Urbina, J
    Pardo, F
    Mir, J
    Loinaz, C
    Herrera, L
    López-Cillero, P
    Santoyo, J
    LIVER TRANSPLANTATION, 2001, 7 (10) : 877 - 883
  • [2] Liver transplantation for elderly patients with early-stage hepatocellular carcinoma
    Endo, Yutaka
    Sasaki, Kazunari
    Moazzam, Zorays
    Lima, Henrique A.
    Alaimo, Laura
    Munir, Muhammad Musaab
    Shaikh, Chanza F.
    Schenk, Austin
    Kitago, Minoru
    Pawlik, Timothy M.
    BRITISH JOURNAL OF SURGERY, 2023, 110 (11) : 1527 - 1534
  • [3] Variable survival outcomes in Australian patients with very early-stage and early-stage hepatocellular carcinoma: A retrospective multicenter cohort study
    Abdelmalak, J.
    Lam, E.
    Greenhill, E.
    Zalcberg, J.
    Roberts, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 71 - 72
  • [4] Liver transplantation for early-stage hepatocellular carcinoma:: An intention to treat analysis
    Dezza, M. C.
    Corno, V.
    Lucianetti, A.
    Zambelli, M.
    Guizzetti, M.
    Pinelli, D.
    Sonzogni, A.
    Gaffuri, G.
    Vigano, R.
    Pasulo, L.
    Di Giorgio, M.
    Luca, M. G.
    Colpani, M.
    Verga, G.
    Fagiuoli, S.
    Colledan, M.
    DIGESTIVE AND LIVER DISEASE, 2007, 39 (10) : A43 - A44
  • [5] Comment on: Liver transplantation for elderly patients with early-stage hepatocellular carcinoma
    Malik, Abdullah K.
    Figueiredo, Rodrigo
    White, Steven A.
    BRITISH JOURNAL OF SURGERY, 2024, 111 (01)
  • [6] ORTHOTOPIC LIVER-TRANSPLANTATION FOR PREOPERATIVE EARLY-STAGE HEPATOCELLULAR-CARCINOMA
    TAN, CK
    GORES, GJ
    STEERS, JL
    PORAYKO, MK
    HAY, JE
    RAKELA, J
    WIESNER, RH
    KROM, RAF
    MAYO CLINIC PROCEEDINGS, 1994, 69 (06) : 509 - 514
  • [7] Racial disparities in access to liver transplantation in patients with early-stage hepatocellular carcinoma
    Orozco, Gabriel
    Cannon, Robert M.
    Mei, Xiaonan
    Inabnet, William B.
    Evers, B. Mark
    Gedaly, Roberto
    Goldberg, David S.
    Shah, Malay B.
    SURGERY, 2024, 176 (06) : 1754 - 1760
  • [8] Multimodality Treatment for Early-Stage Hepatocellular Carcinoma: A Bridging Therapy for Liver Transplantation
    Ashoori, N.
    Bamberg, F.
    Paprottka, P.
    Rentsch, M.
    Kolligs, F. T.
    Siegert, S.
    Peporte, A.
    Al-Tubaikh, J. A.
    D'Anastasi, M.
    Hoffmann, R. T.
    Reiser, M. F.
    Jakobs, T. F.
    DIGESTION, 2012, 86 (04) : 338 - 348
  • [9] CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study
    Qiu, Jiliang
    Peng, Baogang
    Tang, Yunqiang
    Qian, Yeben
    Guo, Pi
    Li, Mengfeng
    Luo, Junhang
    Chen, Bin
    Tang, Hui
    Lu, Canliang
    Cai, Muyan
    Ke, Zunfu
    He, Wei
    Zheng, Yun
    Xie, Dan
    Li, Binkui
    Yuan, Yunfei
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07) : 734 - +
  • [10] Outcomes in Elderly Patients Undergoing Liver Transplantation Compared with Liver-Directed Ablative Therapy in Early-Stage Hepatocellular Carcinoma
    Shah, Malay B.
    Villagomez Rubio, Diego A.
    Orozco, Gabriel
    Desai, Siddharth
    Ancheta, Alexandre
    Gupta, Meera
    Mei, Xiaonan
    Evers, B. Mark
    Gedaly, Roberto
    Cannon, Robert M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 234 (05) : 892 - 899